The dark side of IFN-γ: its role in promoting cancer immunoevasion
M Mojic, K Takeda, Y Hayakawa - International journal of molecular …, 2017 - mdpi.com
Interferon-γ (IFN-γ) is a pleiotropic cytokine that has long been praised as an important
effector molecule of anti-tumor immunity, capable of suppressing tumor growth through …
effector molecule of anti-tumor immunity, capable of suppressing tumor growth through …
Crosstalk of inflammatory cytokines within the breast tumor microenvironment
O Habanjar, R Bingula, C Decombat… - International journal of …, 2023 - mdpi.com
Several immune and immunocompetent cells, including dendritic cells, macrophages,
adipocytes, natural killer cells, T cells, and B cells, are significantly correlated with the …
adipocytes, natural killer cells, T cells, and B cells, are significantly correlated with the …
The interferon-gamma paradox in cancer
MR Zaidi - Journal of interferon & cytokine research, 2019 - liebertpub.com
Interferon-gamma (IFNG) has long been implicated as a central orchestrator of antitumor
immune responses in the elimination stage of the immunoediting paradigm. However …
immune responses in the elimination stage of the immunoediting paradigm. However …
[PDF][PDF] Combination cancer therapies with immune checkpoint blockade: convergence on interferon signaling
Improving efficacy of immune checkpoint blockade for cancer can be facilitated by
combining these agents with each other and/or with other conventional or targeted …
combining these agents with each other and/or with other conventional or targeted …
Targeting ubiquitin specific proteases (USPs) in cancer immunotherapy: from basic research to preclinical application
H Gao, J Yin, C Ji, X Yu, J Xue, X Guan… - Journal of Experimental …, 2023 - Springer
Tumors have evolved in various mechanisms to evade the immune system, hindering the
antitumor immune response and facilitating tumor progression. Immunotherapy has become …
antitumor immune response and facilitating tumor progression. Immunotherapy has become …
Type I and II interferons in the anti-tumor immune response
SE Fenton, D Saleiro, LC Platanias - Cancers, 2021 - mdpi.com
Simple Summary Interferons are cytokines that play key roles in the activation of cellular
components of the immune response, such as dendritic cells, macrophages and T cells …
components of the immune response, such as dendritic cells, macrophages and T cells …
IFN-γ is required for cytotoxic T cell-dependent cancer genome immunoediting
K Takeda, M Nakayama, Y Hayakawa, Y Kojima… - Nature …, 2017 - nature.com
Genetic evolution that occurs during cancer progression enables tumour heterogeneity,
thereby fostering tumour adaptation, therapeutic resistance and metastatic potential …
thereby fostering tumour adaptation, therapeutic resistance and metastatic potential …
[HTML][HTML] The outstanding antitumor capacity of CD4+ T helper lymphocytes
Over the past decades, tumor-resident immune cells have been extensively studied to
dissect their biological functions and clinical roles. Tumor-infiltrating CD8+ T cells, because …
dissect their biological functions and clinical roles. Tumor-infiltrating CD8+ T cells, because …
The deubiquitylating enzyme USP15 regulates homologous recombination repair and cancer cell response to PARP inhibitors
Abstract Poly-(ADP-ribose) polymerase inhibitors (PARPi) selectively kill breast and ovarian
cancers with defects in homologous recombination (HR) caused by BRCA1/2 mutations …
cancers with defects in homologous recombination (HR) caused by BRCA1/2 mutations …